Abstract
Introduction
Effect of defensins and LL-37 on C. difficile 121 For a total of 10 toxinogenic or non-toxinogenic C. difficile strains the subinhibitory 122 concentrations of the antimicrobial peptides were determined. C. difficile suspensions with a 123 concentration of 1.5 x 10 6 CFU/ml were incubated with the antimicrobial peptides HBD1, 124 HBD2, HBD3, HD5 (all peptides from Peptide Institute, Osaka, Japan) and LL-37 125 (Innovagen, Lund, Sweden) at varying concentrations ranging from 0.5 to 15 g/ml for 90 126 min at 37 °C under anaerobic conditions (AnaeroGen, Oxoid Limited, Hampshire, UK). Then 127 1 μg/ml DiBAC 4 (3) (Invitrogen, Carlsbad, CA) was added and after 10 minutes the 128 suspensions were centrifuged for 10 minutes at 4,500 × g, the pellets were resuspended in 300 129 μl PBS and analyzed by flow cytometry. 130 131
Activity of reduced antimicrobial peptides 132
To reduce the antimicrobial peptides these were preincubated with 10 mM DTT at 37 °C for 2 133 hours (13). The peptides were incubated in the native/oxidized or reduced form with 5 C. 134 difficile strains in a concentration of 15 µg/ml as described above and analyzed by flow 135
cytometry. 136 137 Combined effect of antibiotics and antimicrobial peptides 138
Synergism studies were performed using a concentration of 1 µg/100 µl of the various 139 antimicrobial peptides, since at this peptide concentration alone no significant depolarization 140 of bacteria was observed. Based on pilot experiments we used tigecycline at 0.512 µg/ml, 141 moxifloxacin at 32 µg/ml, piperacillin/tazobactam at 6 µg/ml/4 µg/ml, and meropenem at 64 142 µg/ml for these studies because this concentrations don't lead to a significant depolarization. 143
Suspensions with 1.5 × 10 6 CFU/ml were incubated with the antimicrobial peptides for 30 144 minutes at 37 °C. Subsequently, the antimicrobials were added. After further 8 hours 145 incubation at 37 °C under anaerobic conditions (AnaeroGen, Oxoid Limited, Hampshire,UK), the suspensions were incubated for 10 minutes with 1 μg/ml DiBAC 4 (3). The 147 suspensions were centrifuged for 10 minutes at 4,500 × g and the bacterial pellets were 148 resuspended in 300 μl PBS each. The percentage of depolarized fluorescent bacteria in the 149 suspension was determined by flow cytometry as described below. 150
All experiments were performed at a minimum in duplicates and repeated. 151
152

Flow cytometry 153
In each sample 10,000 events were analyzed on a FACSCalibur™ flow cytometer (BD, 154 Sparks, MD), using Cell Quest software (BD) . With the parameters Forward Scatter and Side 155
Scatter, referring to relative cell size and granularity, the bacterial population was gated for 156 evaluation of the fluorescence 1 (DiBAC 4 (3)) in a corresponding histogram. Antibacterial 157 activity was determined as percentage of fluorescent bacteria with respect to the untreated 158 bacterial control. 159
160
Electron microscopy 161
To visualize the effect of antimicrobial peptides on C. difficile cells, 1.5 × 10 7 bacteria/ml 162 were exposed to HBD3 in a concentration of 200 µg/ml and incubated for 4 hours at 37 °C. 163 (Due to a 10-fold bacteria concentration for microscopy, the concentration of antimicrobial 164 peptides was also increased 10-fold.) Untreated bacteria served as control. After 165 centrifugation, the bacterial pellets were fixed with Karnovsky's fixative. The pellets were 166 embedded in 3.5 % agarose at 37 °C, coagulated at room temperature, and fixed again in 167
Karnovsky's fixative. Postfixation was carried out with 1 % osmium tetroxide containing 1.5 168 % K-ferrocyanide in 0.1 M cacodylate buffer for 2 h. Subsequently the specimens were 169 embedded in glycid ether. Ultra-thin sections, 20-30 nm thick, were mounted on uncoated 170 copper grids and imaged by electron microscopy with a Zeiss LIBRA 120 microscope (CarlInfluence of antimicrobial peptides and antibiotics on toxin release 173
For the antimicrobial peptides that exhibited synergism with antibiotics, HBD3 and LL-37, as 174 well as for HNP1, we investigated the influence on toxin release by C. difficile. 175
The 10 toxinogenic strains were grown overnight in Schaedler broth and adjusted to to 4.5 x 176 10 6 cells/ml in Schaedler broth (BD, Sparks, USA), diluted 1:3 in dH 2 O). The dilution was 177 performed because the salt content in undiluted Schaedler broth has an inhibitory effect on the 178 activity of some antimicrobial peptides. The suspensions were incubated with the respective 179 antimicrobial peptide at a concentration of 10 µg/ml for 30 minutes at 37 °C. The 180 antimicrobials were added in the following concentrations: tigecycline 0.512 µg/ml; 181 moxifloxacin 32 µg/ml; piperacillin/tazobactam at 4 and 6 µg/ml respectively and meropenem 182 64 µg/ml. The bacteria suspensions were incubated for 8 h under anaerobic conditions 183 (AnaeroGen, Oxoid Limited, Hampshire, UK). 100 µl of the suspension were used in a toxin 184 With concentrations of 0.5 or 1 µg/ml no antibacterial effect was seen with all peptides tested. 212 Using higher concentrations of 2.5-15 µg/ml no effect on C. difficile integrity was observed 213 when incubating the strains with the constitutive defensin HBD1. Some strains were 214 marginally affected by the inducible HBD2 or by HD5. In contrast, with concentrations > 5 215 significant differences occurred in the activity of reduced HBD1, HBD2 and HD5 against C. has the strongest activity, followed by LL-37 and HBD2, whereas HBD1 had no or little 267 antimicrobial effect. To our knowledge, this is the first report, which describes antimicrobial 268 activity of defensins on vital C. difficile-cells, whereas activity of LL-37 against C. difficile 269 was recently reported (10).
In a preceding study, the reduced form of HBD1 showed higher antimicrobial activity against 271
Bifidobacterium sp. and Candida albicans (13). In this study reduction of the disulfide bonds 272 led not to a pronounced effect of HBD1 but to a decreased activity of the defensin HBD3 273 against C. difficile-strains. The activity of LL-37 was not influenced by the pretreatment with 274 DTT, because in contrast to the defensins the cathelicidin LL-37 is a linear helical peptide 275 without disulfide bonds in the secondary structure. 276
We found that the flow cytometric test required often higher concentrations of the different 277 antibiotics for depolarization of bacteria than MICs causing growth inhibition found using the 278
Etest. This is in concordance with prior findings (14) 
